Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul 16;2008(3):CD006286.
doi: 10.1002/14651858.CD006286.pub2.

Intranasal corticosteroids for nasal airway obstruction in children with moderate to severe adenoidal hypertrophy

Linjie Zhang  1 , Raúl A Mendoza-Sassi, Juraci A César, Neil K Chadha
Affiliations

Intranasal corticosteroids for nasal airway obstruction in children with moderate to severe adenoidal hypertrophy

Linjie Zhang et al. Cochrane Database Syst Rev. .

Abstract

Background: Adenoidal hypertrophy is generally considered a common condition of childhood. When obstructive sleep apnoea or cardio-respiratory syndrome occurs, adenoidectomy is generally indicated. In less severe cases, non-surgical interventions may be considered, however few medical alternatives are currently available. Intranasal steroids may be used to reduce nasal airway obstruction.

Objectives: To assess the effectiveness of intranasal corticosteroids for improving nasal airway obstruction in children with moderate to severe adenoidal hypertrophy.

Search strategy: Our search included the Cochrane Ear, Nose and Throat Disorders Group Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 2, 2007), MEDLINE (1951 to 2007) and EMBASE (1974 to 2007). All searches were initially performed in May 2007 and updated in April 2008.

Selection criteria: Randomised controlled trials comparing intranasal corticosteroids with placebo or no intervention or other treatment in children aged 0-12 years with moderate to severe adenoidal hypertrophy.

Data collection and analysis: Data from the included trials were extracted and trial quality was assessed by two authors independently. Meta-analysis was not applicable and data were summarised in a narrative format.

Main results: Five randomised trials, including a total of 349 patients, met the inclusion criteria of the review. All trials except one showed significant efficacy of intranasal corticosteroids in improving nasal obstruction symptoms and in reducing adenoid size. The first eight-week cross-over study showed that treatment with beclomethasone (336 micrograms/day) yielded a greater improvement in mean symptom scores than placebo (-18.5 vs. -8.5, P < 0.05) and a larger reduction in mean adenoid/choana ratio than placebo (right, -14% vs. +0.4%, p=0.002; left, -15% vs. -2.0%, p=0.0006) between week 0 and week 4. The second four-week cross-over study demonstrated that the nasal obstruction index decreased by at least 50% from baseline in 38% of patients treated with beclomethasone (400 micrograms/day) between week 0 and week 2, whereas none of the patients treated with placebo had such improvement (p<0.01). The third randomized, parallel-group trial showed that 77.7% of patients treated with mometasone (100 micrograms/day) for 40 days demonstrated an improvement in nasal obstruction symptoms and a decrease in adenoid size, such that adenoidectomy could be avoided, whereas no significant improvement was observed in the placebo group. The fourth randomized, parallel-group trial showed that eight-weeks of treatment with flunisolide (500 micrograms/day) was associated with a lager reduction in adenoid size than isotonic saline solution (p<0.05). In contrast, one randomised, parallel-group trial did not find significant improvement in nasal obstruction symptoms and adenoid size after eight weeks of treatment with beclomethasone (200 micrograms/day).

Authors' conclusions: Limited evidence suggests that intranasal corticosteroids may significantly improve nasal obstruction symptoms in children with moderate to severe adenoidal hypertrophy, and this improvement may be associated with a reduction of adenoid size. The long-term effect of intranasal corticosteroids in these patients remains to be defined.

PubMed Disclaimer

Conflict of interest statement

None known.

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Berlucchi 2007 {published data only}
    1. Berlucchi M, Salsi D, Valetti L, Parrinello G, Nicolai P. The role of mometasone furoate aqueous nasal spray in the treatment of adenoidal hypertrophy in the pediatric age group: preliminary results of a prospective, randomized study. Pediatrics 2007;119:e1392‐7. - PubMed
Ciprandi 2007 {published data only}
    1. Ciprandi G, Varricchio A, Capasso M, Varricchio AM, Lucia A, Ascione E, et al. Intranasal flunisolide treatment in children with adenoidal hypertrophy. International Journal of Immunopathology and Pharmacology 2007;20(4):833‐6. - PubMed
Criscuoli 2003 {published data only}
    1. Criscuoli G, D'Amora S, Ripa G, Cinquegrana G, Mansi N, Impagliazzo N, et al. Frequency of surgery among children who have adenotonsillar hypertrophy and improve after treatment with nasal beclomethasone. Pediatrics 2003;111:e236‐8. - PubMed
Demain 1995 {published data only}
    1. Demain JG, Goetz DW. Pediatric adenoidal hypertrophy and nasal airway obstruction: reduction with aqueous nasal beclomethasone. Pediatrics 1995;95:355‐64. - PubMed
Demirhan 2010 {published data only}
    1. Demirhan H, Aksoy F, Özturan O, Yildirim YS, Veyseller B. Medical treatment of adenoid hypertrophy with "fluticasone propionate nasal drops". International Journal of Pediatric Otorhinolaryngology 2010;74(7):773‐6. - PubMed
Lepcha 2002 {published data only}
    1. Lepcha A, Kurien M, Job A, Jeyaseelan L, Thomas K. Chronic adenoid hypertrophy in children ‐ is steroid nasal spray beneficial?. Indian Journal of Otolaryngology and Head and Neck Surgery 2002;54(4):280‐4. - PMC - PubMed

References to studies excluded from this review

Berlucchi 2008 {published data only}
    1. Berlucchi M, Valetti, Parrinello, Nicolai P. Long‐term follow‐up of children undergoing topical intranasal steroid therapy for adenoidal hypertrophy. International Journal of Pediatric Otorhinolaryngology 2008;72:1171‐5. - PubMed
Brouillette 1982 {published data only}
    1. Brouillette RT, Fernbach SK, Hunt CE. Obstructive sleep apnea in infants and children. Journal of Pediatrics 1982;100(1):31‐40. - PubMed
Cengel 2006 {published data only}
    1. Cengel S, Akyol MU. The role of topical nasal steroids in the treatment of children with otitis media with effusion and/or adenoid hypertrophy. International Journal of Pediatric Otorhinolaryngology 2006;70:639‐45. - PubMed
Varricchio 2009 {published data only}
    1. Varricchio A, Tortoriello G, Capasso M, Lucia A, Marchisio P, Varrichio AM, et al. Prevention of surgery in children with adenoidal hypertrophy treated with intranasal flunisolide: 12‐month follow‐up. Journal of Biological Regulator & Homeostatic Agents 2009;23(2):95‐101. - PubMed

Additional references

Adamopoulos 1995
    1. Adamopoulos G, Manolopoulos L, Giotakis I. A comparison of the efficacy and patient acceptability of budesonide and beclomethasone dipropionate aqueous nasal sprays in patients with perennial rhinitis. Clinical Otolaryngology and Allied Sciences 1995;20:340‐4. - PubMed
Al Sayyad 2007
    1. Al Sayyad JJ, Fedorowicz Z, Alhashimi D, Jamal A. Topical nasal steroids for intermittent and persistent allergic rhinitis in children. Cochrane Database of Systematic Reviews 2007, Issue 4. [Art. No.: CD003163. DOI: 10.1002/14651858.CD003163.pub4] - PMC - PubMed
Brodsky 1993
    1. Brodsky L, Koch J. Bacteriology and immunology of normal and diseased adenoids in children. Archives of Otolaryngology ‐ Head and Neck Surgery 1993;119:821‐9. - PubMed
Chisholm 2005
    1. Chisholm EJ, Lew‐Gor S, HajioffD, Caulfield H. Adenoid size assessment: a comparison of palpation, nasendoscopy and mirror examination. Clinical Otolaryngology 2005;30:39‐41. - PubMed
Cohen 1985
    1. Cohen D, Konak S. The evaluation of radiographs of the nasophaynx. Clinical Otolaryngology and Allied Sciences 1985;10:73‐8. - PubMed
Fujioka 1979
    1. Fujioka M, Young LW, Girdany BR. Radiographic evaluation of adenoidal size in children: adenoidal‐nasopharyngeal ratio. American Journal of Radiology 1979;173:401‐4. - PubMed
Gates 1992
    1. Gates GA, Muntz HR, Gaylis B. Adenoidectomy and otitis media. Annals of Otology, Rhinology and Laryngology 1992;101:24‐32. - PubMed
Gazis 1999
    1. Gazis AG, Homer JJ, Henson DB, Jones NS. The effect of six weeks of topical betamethasone drops on the hypothalamo‐pituitary‐adrenal axis and bone turnover in patients with nasal polyposis. Clinical Otolaryngology and Allied Sciences 1999;24:495‐8. - PubMed
Gozal 1998
    1. Gozal D. Sleep‐disordered breathing and school performance in children. Pediatrics 1998;102:616‐20. - PubMed
Grimmer 2005
    1. Grimmer JF, Poe DS. Update on Eustachian tube dysfunction and the patulous Eustachian tube. Current Opinion in Otolaryngology and Head and Neck Surgery 2005;13:277‐82. - PubMed
Guilleminault 1981
    1. Guilleminault C, Korobkin R, Winkle R. A review of 50 children with obstructive sleep apnea syndrome. Lung 1981;159:275‐87. - PubMed
Handbook 2009
    1. Higgins JPT, Green S (editors). Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2008. Available from www.cochrane‐handbook.org.
Jadad 1996
    1. Jadad A, Moore AR, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Controlled Clinical Trials 1996;17:1‐12. - PubMed
Javadyan 2003
    1. Javadyan A, Papadopoulos NG, Kafetzis DA. Rhinovirus infections and adenoidal hypertrophy: do they interact with atopy in children?. Expert Review of Anti‐infective Therapy 2003;1:223‐9. - PubMed
Johanneson 1968
    1. Johanneson S. Roentgenologic investigation of the nasopharyngeal tonsil in children of different ages. Acta Radiologica: Diagnosis 1968;7:299‐304. - PubMed
Kenna 2000
    1. Kenna MA. Tonsils and adenoids. In: Behrman RE, Kliegman RM, Jenson HB editor(s). Nelson Textbook of Pediatrics. 16th Edition. Philadelphia: W.B. Saunders, 2000:1267‐8.
LaForce 1985
    1. LaForce C, Davis V. Nasal perforation in patients using intranasal beclomethasone dipropionate (BDP). Journal of Allergy and Clinical Immunology 1985;75:186.
Lim 2009
    1. Lim J, McKean M. Adenotonsillectomy for obstructive sleep apnoea in children. Cochrane Database of Systematic Reviews 2006, Issue 2. [Art. No.: CD003136. DOI: 10.1002/14651858.CD003136.pub2] - PubMed
Mary 2005
    1. Mary K, Anjali L, John M, Arif A, Jeyaseelan L. X‐rays in the evaluation of adenoid hypertrophy: its role in the endoscopic era. Journal of Indian Association of Pediatric Surgeons 2005;57:45‐7. - PMC - PubMed
Menashe 1965
    1. Menashe V, Farrehi F, Miller M. Hypoventilation and cor pulmonale due to chronic upper airway obstruction. Journal of Pediatrics 1965;67:198‐203.
Modrzynski 2005
    1. Modrzynski M, Potyra F, Zawisza E. Radiographic evaluation of adenoidal size in children with allergic perennial rhinitis: still the current method. Polish Journal of Radiology 2005;70:13‐7.
Neri 2004
    1. Neri G, Mennucci E, Ortore R, Leone O, Croce A. Rhinopharynx endoscopy in the diagnosis of chronic otitis media with effusion in infancy. Acta Otorhinolaryngologica Italica 2004;24:63‐7. - PubMed
Paradise 1995
    1. Paradise JL. Tonsillectomy and adenoidectomy. In: Bluestone CD, Stool SE editor(s). Pediatric Otolaryngology. 3rd Edition. Philadelphia: W.B. Saunders, 1995:1054‐65.
Paradise 1998
    1. Paradise JL, Bernard BS, Colborn K, Janosky JE. Assessment of adenoidal obstruction in children: clinical signs versus roentgenographic findings. Pediatrics 1998;101:979‐86. - PubMed
Raphael 1987
    1. Raphael G, Kaliner M. Allergy and the pharyngeal lymphoid tissues. Otolaryngologic Clinics of North America 1987;20:295‐304. - PubMed
Rutkow 1986
    1. Rutkow IM. Ear, nose, and throat operations in the United States. Archives of Otolaryngology ‐ Head and Neck Surgery 1986;112:873‐6. - PubMed
Sclafani 1998
    1. Sclafani AP, Ginsburg J, Shah MK, Dolistsky JN. Treatment of symptomatic chronic adenotonsillar hypertrophy with amoxicillin/clavulanate potassium: short‐ and long‐term results. Pediatrics 1998;101:675‐81. - PubMed
Skoner 2000
    1. Skoner DP, Rachelefsky GS, Meltzer EO, Chervinsky P, Morris RM, Seltzer JM, et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics 2000;105:E23. - PubMed
Taramarcaz 2003
    1. Taramarcaz P, Gibson PG. Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis. Cochrane Database of Systematic Reviews 2003, Issue 3. [Art. No.: CD003570. DOI: 10.1002/14651858.CD003570] - PMC - PubMed
Wang 1992
    1. Wang D, Clement P, Kaufman L, Derde MP. Fiberoptic examination of the nasal cavity and nasopharynx in children. International Journal of Pediatric Otolaryngology 1992;24:35‐44. - PubMed
Wang 1994
    1. Wang D, Clement P, Kaufman L, Derde MP. Fiberoptic evaluation of the nasal and nasopharyngeal anatomy in children with snoring. Journal of Otolaryngology 1994;23:57‐60. - PubMed
Wormald 1992
    1. Wormald PJ, Prescott CA. Adenoids: comparison of radiological assessment methods with clinical and endoscopic findings. Journal of Laryngology and Otology 1992;106:342‐4. - PubMed

References to other published versions of this review

Chadha 2009
    1. Chadha NK, Zhang L, Mendoza‐Sassi RA, César JA. Using nasal steroids to treat nasal obstruction caused by adenoid hypertrophy: does it work?. Otolaryngology ‐ Head and Neck Surgery 2009;140(2):139‐47. - PubMed

Publication types

MeSH terms

Substances